- Stocks
- Healthcare
- NYSEAMERICAN: PTN

Price (delayed)

$1.73

Market cap

$27.92M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.51

Enterprise value

$18.61M

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop

Palatin Technologies's debt has decreased by 14% from the previous quarter and by 12% YoY

The company's EPS rose by 8% QoQ and by 7% YoY

PTN's equity has surged by 114% since the previous quarter but it has dropped by 84% year-on-year

PTN's gross profit has surged by 65% year-on-year but it is down by 16% since the previous quarter

The net income has contracted by 22% YoY

What are the main financial stats of PTN

Market
Valuations
Earnings

Shares outstanding

16.14M

Market cap

$27.92M

Enterprise value

$18.61M

Price to earnings (P/E)

N/A

Price to book (P/B)

17.68

Price to sales (P/S)

4.63

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.15

Revenue

$5.9M

EBIT

-$32.87M

EBITDA

-$32.53M

Free cash flow

-$34.68M

Per share
Balance sheet
Liquidity

EPS

-$2.51

Free cash flow per share

-$2.2

Book value per share

$0.1

Revenue per share

$0.37

TBVPS

$0.72

Total assets

$11.41M

Total liabilities

$9.83M

Debt

$706,641

Equity

$1.58M

Working capital

$1.74M

Debt to equity

0.45

Current ratio

1.2

Quick ratio

1.17

Net debt/EBITDA

0.29

Margins
Efficiency
Dividend

EBITDA margin

-551.2%

Gross margin

96.6%

Net margin

-557.1%

Operating margin

-423.1%

Return on assets

-242.9%

Return on equity

N/A

Return on invested capital

N/A

Return on capital employed

-1,143.8%

Return on sales

-556.9%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Palatin Technologies stock price performed over time

Intraday

0%

1 week

-5.46%

1 month

-8.47%

1 year

-15.61%

YTD

-56.53%

QTD

-11.28%

How have Palatin Technologies's revenue and profit performed over time

Revenue

$5.9M

Gross profit

$5.7M

Operating income

-$24.97M

Net income

-$32.88M

Gross margin

96.6%

Net margin

-557.1%

PTN's gross profit has surged by 65% year-on-year but it is down by 16% since the previous quarter

The company's operating margin has surged by 53% YoY but it fell by 30% QoQ

The revenue has surged by 53% year-on-year but it has declined by 17% since the previous quarter

PTN's operating income is up by 28% year-on-year but it is down by 8% since the previous quarter

What is Palatin Technologies's growth rate over time

What is Palatin Technologies stock price valuation

P/E

N/A

P/B

17.68

P/S

4.63

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.15

The company's EPS rose by 8% QoQ and by 7% YoY

PTN's equity has surged by 114% since the previous quarter but it has dropped by 84% year-on-year

The revenue has surged by 53% year-on-year but it has declined by 17% since the previous quarter

The stock's price to sales (P/S) is 11% less than its last 4 quarters average of 5.2

How efficient is Palatin Technologies business performance

PTN's return on assets has dropped by 173% year-on-year and by 25% since the previous quarter

The company's return on sales rose by 32% YoY but it fell by 19% QoQ

What is PTN's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for PTN.

How did Palatin Technologies financials performed over time

The total assets is 16% greater than the total liabilities

The company's total liabilities has shrunk by 60% QoQ and by 39% YoY

The total assets has dropped by 55% year-on-year and by 16% since the previous quarter

Palatin Technologies's debt is 55% less than its equity

PTN's equity has surged by 114% since the previous quarter but it has dropped by 84% year-on-year

Palatin Technologies's debt has decreased by 14% from the previous quarter and by 12% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.